Newsroom

Viruszellen
News
Inactivated viruses for vaccine development
The GSI Helmholtzzentrum für Schwerionenforschung and the FAIR GmbH (GSI/FAIR) uses its research potential and unique infrastructure to contribute to the management of the current corona pandemic. In several areas at GSI/FAIR, scientists are working to provide new insights and technologies that may help to fight the corona virus SARS-CoV-2. In cooperation with the Helmholtz Centre for Infection Research (HZI) in Braunschweig, methods for virus inactivation are being tested. These inactivated viruses are used for vaccine development. To this aim, the accelerators and laboratories on the Darmstadt campus are also being used. The laboratory is operational, while strictly abiding to safety regulations.
16.04.2020
HZI Campus
Abbildung eines Corona-Virus
News
Helmholtz position paper on the epidemiological situation
Researchers from the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Forschungszentrum Jülich (FZJ) are modelling the further course of the epidemic, taking into account various scenarios for relaxing the ban on contact and making recommendations.
14.04.2020
HZI Campus
Coronavirus
News
"It's too early to ease restrictions"
Scientists from the Helmholtz Centre for Infection Research (HZI) in Braunschweig are simulating the effect of various conditions on the development of the SARS-CoV-2 epidemic in Germany. Their results suggest that the restrictions in social life are effective and that a further slowing of the spread is possible. In order to protect the health system from overload, they urgently warn against easing the restrictions already now. They have published their preliminary results, which have not yet been peer-reviewed, on a preprint server for quick scientific use.
08.04.2020
HZI Campus
Viren
News
Step-by-step Plan for after the Shutdown
An interdisciplinary group of renowned scientists - among them Prof Gérard Krause, head of the Department Epidemiology at the Helmholtz Centre for Infection Research (HZI) in Braunschweig - is now calling for the current restrictions in society and the economy to be gradually eased, while ensuring medical care for the entire population.
04.04.2020
HZI Campus
Die SORMAS-App in der Anwendung.
News
SORMAS supports German health authorities in contact person management
The Covid-19 pandemic affects more and more countries worldwide. Since the virus causes no or only mild symptoms in many infected people, researchers assume that the number of unreported cases is high. In order to slow down the further spread of the virus, health authorities are focusing on consistent management of contact persons of confirmed cases of infection. For this purpose, the German Public Health Service (ÖGD) will be able to use a special version of the SORMAS disease control app in the future.
01.04.2020
HZI Campus
Viruszellen
News
"We are not defenceless against the novel coronavirus"
27.03.2020
HZI Campus

HZI in the media

Seuchen aus dem KI-Labor: Kann Künstliche Intelligenz bereits Biowaffen bauen?

... beeindruckendes Ergebnis“, sagt Jakob Wirbel vom Helmholtz-Zentrum für Infektionsforschung (HZI). „Trotzdem schlafe ich momentan noch ...

15.10.2026
|
Der Tagesspiegel
Impfung sinnvoll? Erst Erkältungen, dann Corona und Grippe – So schützen Sie sich

... Lange, Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und Mitglied der Ständigen ...

14.10.2026
|
DIE WELT
HMN 2026: How crawling motility may be far older than previously thought

also included Japanese microbiologists and collaborators from IST Austria and HZI Braunschweig (Germany), demonstrated that actin inhibitors

14.10.2026
|
Health Medicine Network
Neue Empfehlungen der WHO zur COVID-19-Impfung

... in der Abteilung „Virale Immunologie“ am Helmholtz-Zentrum für Infektionsforschung (HZI), hat die WHO als externer ...

13.10.2026
|
DeutschesGesundheitsPortal
Metax brings genome-wide coverage into focus for sharper microbial profiling

tool called Metax, developed by researchers at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and described in the

12.10.2026
|
Bioengineer.org
New Hope for Fighting C. difficile Infections

parts of the microbiome. HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University. “We

12.10.2026
|
Technology Networks
HZI erhält 724.000 Euro: Makrophagen sollen Lungenfibrose bekämpfen

... auch gezielte Forschungsmittel an das Helmholtz-Zentrum für Infektionsforschung (HZI): Die Forschungsgruppe von Prof ...

12.10.2026
|
Ad Hoc News
Fieser Magen-Darm-Erreger breitet sich immer stärker aus: Infektionen in England steigen drastisch

... nur in England vor. Laut Angaben des Helmholtz Zentrum für Infektionsforschung ist es dem Erreger ...

12.10.2026
|
Frankfurter Rundschau online
EU fördert Entwicklung von Immunzelltherapie bei Lungenfibrose

... und Belgien. Aus Deutschland sind das Helmholtz-Zentrum für Infektionsforschung (HZI), das Fraunhofer-Institut für Toxikologie und ...

12.10.2026
|
MTA Dialog
Forscher entwickeln Wirkstoff gegen Pockenviren

... weitere Versuche herstellen.

 

Auch das Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig ist beteiligt. Die ...

11.10.2026
|
t-online.de
Warum Ballaststoffe nicht bei jedem gleich wirken

... unterschiedlichen Regionen unterscheidet. Der Forscher vom Helmholtz-Zentrum für Infektionsforschung konnte in seiner Studie zeigen, ...

10.10.2026
|
rbb radioeins
Gut bacteria team up with diet to decide who rules the microbiome

Tawk, Youssef El Mouali and colleagues at the Helmholtz Centre for Infection Research, together with collaborators at the University of

09.10.2026
|
Bioengineer.org

Register now for the HZI newsletter